Journal History
| 2009 | The inaugural issue was released. Cancers was published as a quarterly journal. |
| 2013 | Cancers was indexed in PubMed (NLM) and Scopus. |
| 2015 | Cancers changed to publish in article number order instead of in page range order. |
| 2016 | Cancers adopted a monthly publication schedule. Cancers announced the first edition of the Travel Awards. The journal Twitter account was established. |
| 2017 | Cancers was indexed in Science Citation Index Expanded (SCIE)—Web of Science (Clarivate Analytics). |
| 2018 | Cancers received its first Impact Factor (5.326), ranked 44/222 (Q1) in "Oncology". |
| 2019 | Cancers received its 2018 Impact Factor (6.162), ranked 31/229 (Q1) in "Oncology" in JCR. Signal Transduction Society (STS) became affiliated to Cancers. |
| 2020 | Cancers established the following sections: - Molecular Cancer Biology; - Cancer Immunology and Immunotherapy; - Cancer Biomarkers; - Cancer Epidemiology and Prevention; - Cancer Pathophysiology; - Tumor Microenvironment; - Cancer Causes, Screening and Diagnosis; - Cancer Nursing and Care; - Cancer Therapy; - Clinical Trials of Cancer; - Systematic Review or Meta-Analysis in Cancer Research; - Methods and Technologies Development; - Cancer Informatics and Big Data. Cancers announced the first edition of the Outstanding Reviewer Awards and second edition of the Young Investigator Awards. Cancers published its 5,000th paper. |
| 2021 | Cancers adopted a semi-monthly publication schedule. Cancers received its 2020 Impact Factor (6.639), ranked 51/242 (Q1) in "Oncology". Cancers published its 10,000th paper. Cancers established the following sections: - Pediatric Oncology; - Infectious Agents and Cancer. |
| 2022 |
- Cancer Nursing and Care was renamed as Transplant Oncology and Cancer Nursing Care. |
| 2023 |
Cancers received its 2022 Impact Factor (5.2), ranked 72/241 (Q2) in "Oncology". |
Editor-in-Chief
| 2009–2015 | Editor-in-Chief: Prof. Dr. Robert H. Weiss |
| 2015–present | Editor-in-Chief: Prof. Dr. Samuel C. Mok |
Section Editor-in-Chief
| 2020–2022 | Section Editor-in-Chief: Prof. Dr. Eduardo Nagore for the section on Cancer Epidemiology and Prevention |
| 2020–present | Section Editor-in-Chief: Dr. Carlos S. Moreno for the section on Cancer Biomarkers Section Editor-in-Chief: Prof. Dr. Donat Kögel for the section on Molecular Cancer Biology Section Editor-in-Chief: Dr. Barbara Wegiel for the section on Cancer Immunology and Immunotherapy Section Editor-in-Chief: Dr. Nicola Amodio for the section on Cancer Pathophysiology Section Editor-in-Chief: Prof. Dr. Sanjay Gupta for the section on Tumor Microenvironment Section Editor-in-Chief: Dr. Kevin Camphausen for the section on Cancer Therapy Section Editor-in-Chief: Prof. Dr. Alexandre Escargueil for the section on Cancer Therapy Section Editor-in-Chief: Prof. Dr. Massimo Di Maio for the section on Systematic Review or Meta-Analysis in Cancer Research Section Editor-in-Chief: Dr. Jason Roszik for the section on Cancer Informatics and Big Data Section Editor-in-Chief: Prof. Dr. Massoud Mirshahi for the section on Cancer Causes, Screening and Diagnosis |
| 2021–2022 | Section Editor-in-Chief: Prof. Dr. Antoine Italiano for the section on Clinical Trials of Cancer |
| 2022–2023 | Section Editor-in-Chief: Dr. Maen Abdelrahim for the section on Transplant Oncology and Cancer Nursing Care |
| 2020–2023 | Section Editor-in-Chief: Prof. Dr. Fiona Lyng for the section on Methods and Technologies Development |
| 2022–present | Section Editor-in-Chief: Dr. Sam Mbulaiteye for the section on Infectious Agents and Cancer Section Editor-in-Chief: Prof. Dr. Anupam Bishayee for the section on Cancer Drug Development Section Editor-in-Chief: Prof. Dr. Sanjay K. Srivastava for the section on Cancer Metastasis |
| 2023–present |
Section Editor-in-Chief: Dr. Maen Abdelrahim for the section on Transplant Oncology |
| 2024–present |
Section Editor-in-Chief: Prof. Dr. Sebastiano Mercadante for the section on Cancer Survivorship and Quality of Life |
